9.57
-0.11(-1.14%)
Currency In USD
| Previous Close | 9.68 |
| Open | 9.68 |
| Day High | 9.69 |
| Day Low | 9.42 |
| 52-Week High | 15.69 |
| 52-Week Low | 8.03 |
| Volume | 1.46M |
| Average Volume | 2.14M |
| Market Cap | 1.54B |
| PE | 136.71 |
| EPS | 0.07 |
| Moving Average 50 Days | 10.96 |
| Moving Average 200 Days | 11.27 |
| Change | -0.11 |
If you invested $1000 in Certara, Inc. (CERT) since IPO date, it would be worth $251.31 as of December 04, 2025 at a share price of $9.57. Whereas If you bought $1000 worth of Certara, Inc. (CERT) shares 3 years ago, it would be worth $540.07 as of December 04, 2025 at a share price of $9.57.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Certara Automates Scientific Workflows with Phoenix® Cloud
GlobeNewswire Inc.
Nov 04, 2025 1:00 PM GMT
New cloud capabilities cut time to create Tables, Figures, and Listings by 50%RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio,
Certara Expands Biosimulation Market with AI-Driven QSP Platform
GlobeNewswire Inc.
Oct 30, 2025 8:15 PM GMT
Certara IQ™ integrates AI and biosimulation to accelerate R&D productivity, reduce risk, and deepen understanding of novel and complex therapiesRADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-in
Certara Scientists are Among the Topmost Cited Biopharma Researchers
GlobeNewswire Inc.
Oct 20, 2025 12:00 PM GMT
Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,